Neoplasia/BPH

	Patient-Reported Outcomes on Quality of Life and Psychological Distress After Focal High-Intensity Focused Ultrasound for Prostate Cancer: Prospective Multicenter Study. JMIR Cancer Franz T, Hartung C, Ganzer R, Holze S, Stolzenburg JU. PMID: 42295325 [PubMed - indexed for MEDLINE]
	Preliminary clinical association between the Nerve-Sparing Quality (NSQ) Score and early functional outcomes after robot-assisted radical prostatectomy. Folia Med Cracov Kempisty J, Balawander K, D, Burdziak K. PMID: 42295074 [PubMed - indexed for MEDLINE]
	Intraoperative Hypotension During Photodynamic Diagnosis-Guided TURBT Under Spinal Anesthesia: A Propensity Score-Matched and Logistic Regression Analysis. Int J Urol Igarashi A, Kinoshita T, Fujita M, Obayashi R, Yamamoto A, Yamamoto R, Akagi N, Shibasaki N, Kawakita M, Yamasaki T. PMID: 42295047 [PubMed - indexed for MEDLINE]
	Multi-Center, Real-World Registry Study of the UroLift Prostatic Urethral Lift (PUL) for Benign Prostatic Hyperplasia (BPH) in Japan. Int J Urol Masumori N, Takahashi S, Anan G, Endo F, Furuta A, Haga K, Hatanaka M, Kato S, Komai Y, Kyoda Y, Matsuyama N, Murayama S, Nagamatsu H, Obinata D, Sekiguchi Z, Waseda Y. PMID: 42294858 [PubMed - indexed for MEDLINE]
	TURBT versus RC in T1N0M0 non-urothelial bladder cancer: a population-based study. Front Oncol He Q, Chen Y, Zhang T, Sheng W, Huang J. PMID: 42294298 [PubMed]
	Development and validation of a machine learning-based radiomics model using 45-keV virtual monoenergetic images for differentiating fat-poor angiomyolipoma from clear cell renal cell carcinoma. Transl Androl Urol Jing S, Wang J, Zhao X, Zeng B, Luo J, Yang Z, Liu Y. PMID: 42293856 [PubMed]
	NOX4 suppresses malignant progression in prostate adenocarcinoma and functions as a potential diagnostic biomarker. Transl Androl Urol Hu J, Zhou M, Wu X, Hu M. PMID: 42293855 [PubMed]
	Future direction of systemic therapy for advanced renal cell carcinoma: lessons from final and extended follow-up data from the CheckMate 9ER trial. Transl Androl Urol Ishihara H. PMID: 42293852 [PubMed]
	Electrolyte trajectory-based subphenotypes and their association with hospital length of stay in prostate cancer patients. Transl Androl Urol Shen Y, Xuan H, Wang J, Hu Y, Zhang Y. PMID: 42293848 [PubMed]
	Diagnostic potential of urinary PENK methylation for bladder cancer in patients with hematuria: insights from a prospective and multi-institutional study. Transl Androl Urol Koguchi D, Shiba I, Shiono Y, Matsumoto K. PMID: 42293844 [PubMed]
	Analysis of factors affecting the upstaging and downstaging of renal cell carcinoma from T1 to T3a and the impact of different surgical approaches on patient prognosis and survival: a multicenter retrospective study. Transl Androl Urol Zhang Y, Baerbieke Y, Fan J, Ma C, Zhuang Y, Li J, Wang Z, Zeng J, Shi X, Yang T, Pei X, Li X. PMID: 42293838 [PubMed]
	Association between prognostic nutritional index (PNI)/Controlling Nutritional Status (CONUT) score and prognosis in patients with bladder cancer: a systematic review and meta-analysis. Transl Androl Urol Chen Y, Zheng J, Li D, Wu Q, Ren Q. PMID: 42293833 [PubMed]
	Utilizing intraoperative frozen section examination (IFSE) for diagnosis and treatment in a high-clinical-suspicion prostate cancer (PCa) cohort based on (18)F-PSMA PET/CT and MRI: a pilot study. Transl Androl Urol Zhu LY, Fang M, Luan Y, Huang TB, Lu SM, Xiao Q, Chen J, Tan X, Ding XF. PMID: 42293831 [PubMed]
	Site-specific heterogeneity in treatment response among patients with metastatic bladder cancer: implications for oligometastatic disease-a retrospective cohort study. Transl Androl Urol Wang T, Wei B. PMID: 42293828 [PubMed]
	Dietary patterns and knowledge-attitude-practice factors are associated with late recurrence of non-muscle-invasive bladder cancer: a case-control study. Front Nutr Wu Q, Qing X, Gao W. PMID: 42293220 [PubMed]
	Determining the Correlation and Effect of Rectal and Bladder Volume Change in Shift of Planning Target Volume and Calculating Planning Target Volume Margin with Van Herk Formula in Prostate Cancer Tomotherapy. J Biomed Phys Eng Shabaninejad V, Shanei A, Roayaei M, Akhavan A, Saeb M, Hadinezhad S. PMID: 42292680 [PubMed]
	From molecular networks to translational intervention: current progress in the mechanisms of gemcitabine resistance in bladder cancer. Front Immunol Jin M, Cai Z, Bu M, Liu J, Zhang X. PMID: 42292383 [PubMed - indexed for MEDLINE]
	Pulmonary Fibrosis and Pulmonary Function in Patients with Metastatic Testicular Cancer During and after Combination Chemotherapy: The BLEOTOX Study. Eur Urol Open Sci Frey L, Grunwald S, Ruckes C, Duwe G, Wohlleber K, Frey LJ, Haack M, Rölz N, Dotzauer R, Korczynski D, Axel Haferkamp A, Brandt MP. PMID: 42291633 [PubMed]
	Next-generation imaging in prostate cancer. Front Urol Rabie A, Buscarini M, Zaytoun O. PMID: 42291630 [PubMed]
	Bone remodeling: a central mechanism in prostate cancer bone metastasis. PeerJ Tang H, Chen J, Wu H, Lv Y, Wa Q, He S. PMID: 42291433 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 188653

Page 1 of 9433



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy